1C0 fundamentals
CELYAD ONCOLOGY S.A. earnings per share and revenue
Next report date
Report periodH2 2024
EPS estimate—
Revenue estimate—
EPS
Forecast
H1 '20
H2 '20
H1 '21
H2 '21
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
H1 '25
−0.84
−0.63
−0.42
−0.21
0.00
Reported
Estimate
Currency: EUR
H1 '20
H2 '20
H1 '21
H2 '21
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
H1 '25
Reported
—
−0.17
—
—
—
—
Estimate
−0.81
−0.80
−0.78
—
—
—
Surprise
—
+78.75%
—
—
—
—
Revenue
Forecast
H1 '20
H2 '20
H1 '21
H2 '21
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
H1 '25
0.00
11.00 K
22.00 K
33.00 K
44.00 K
Reported
Estimate
Currency: EUR
H1 '20
H2 '20
H1 '21
H2 '21
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
H1 '25
Reported
—
44.00 K
—
—
—
—
Estimate
0.00
—
—
—
—
—
Surprise
—
—
—
—
—
—